-
Je něco špatně v tomto záznamu ?
Time-Averaged Wavefront Analysis Demonstrates Preferential Pathways of Atrial Fibrillation, Predicting Pulmonary Vein Isolation Acute Response
CH. Roney, N. Child, B. Porter, I. Sim, J. Whitaker, RH. Clayton, JI. Laughner, A. Shuros, P. Neuzil, SE. Williams, RS. Razavi, M. O'Neill, CA. Rinaldi, P. Taggart, M. Wright, JS. Gill, SA. Niederer
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- Publikační typ
- časopisecké články MeSH
Electrical activation during atrial fibrillation (AF) appears chaotic and disorganised, which impedes characterisation of the underlying substrate and treatment planning. While globally chaotic, there may be local preferential activation pathways that represent potential ablation targets. This study aimed to identify preferential activation pathways during AF and predict the acute ablation response when these are targeted by pulmonary vein isolation (PVI). In patients with persistent AF (n = 14), simultaneous biatrial contact mapping with basket catheters was performed pre-ablation and following each ablation strategy (PVI, roof, and mitral lines). Unipolar wavefront activation directions were averaged over 10 s to identify preferential activation pathways. Clinical cases were classified as responders or non-responders to PVI during the procedure. Clinical data were augmented with a virtual cohort of 100 models. In AF pre-ablation, pathways originated from the pulmonary vein (PV) antra in PVI responders (7/7) but not in PVI non-responders (6/6). We proposed a novel index that measured activation waves from the PV antra into the atrial body. This index was significantly higher in PVI responders than non-responders (clinical: 16.3 vs. 3.7%, p = 0.04; simulated: 21.1 vs. 14.1%, p = 0.02). Overall, this novel technique and proof of concept study demonstrated that preferential activation pathways exist during AF. Targeting patient-specific activation pathways that flowed from the PV antra to the left atrial body using PVI resulted in AF termination during the procedure. These PV activation flow pathways may correspond to the presence of drivers in the PV regions.
Boston Scientific Corp St Paul MN United States
Department of Cardiology Guy's and St Thomas' Hospital London United Kingdom
Department of Cardiology Na Holmolce Hospital Prague Czechia
Institute of Cardiovascular Science University College London London United Kingdom
School of Biomedical Engineering and Imaging Sciences King's College London London United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22001681
- 003
- CZ-PrNML
- 005
- 20220112153657.0
- 007
- ta
- 008
- 220107s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fphys.2021.707189 $2 doi
- 035 __
- $a (PubMed)34646149
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Roney, Caroline H $u School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom
- 245 10
- $a Time-Averaged Wavefront Analysis Demonstrates Preferential Pathways of Atrial Fibrillation, Predicting Pulmonary Vein Isolation Acute Response / $c CH. Roney, N. Child, B. Porter, I. Sim, J. Whitaker, RH. Clayton, JI. Laughner, A. Shuros, P. Neuzil, SE. Williams, RS. Razavi, M. O'Neill, CA. Rinaldi, P. Taggart, M. Wright, JS. Gill, SA. Niederer
- 520 9_
- $a Electrical activation during atrial fibrillation (AF) appears chaotic and disorganised, which impedes characterisation of the underlying substrate and treatment planning. While globally chaotic, there may be local preferential activation pathways that represent potential ablation targets. This study aimed to identify preferential activation pathways during AF and predict the acute ablation response when these are targeted by pulmonary vein isolation (PVI). In patients with persistent AF (n = 14), simultaneous biatrial contact mapping with basket catheters was performed pre-ablation and following each ablation strategy (PVI, roof, and mitral lines). Unipolar wavefront activation directions were averaged over 10 s to identify preferential activation pathways. Clinical cases were classified as responders or non-responders to PVI during the procedure. Clinical data were augmented with a virtual cohort of 100 models. In AF pre-ablation, pathways originated from the pulmonary vein (PV) antra in PVI responders (7/7) but not in PVI non-responders (6/6). We proposed a novel index that measured activation waves from the PV antra into the atrial body. This index was significantly higher in PVI responders than non-responders (clinical: 16.3 vs. 3.7%, p = 0.04; simulated: 21.1 vs. 14.1%, p = 0.02). Overall, this novel technique and proof of concept study demonstrated that preferential activation pathways exist during AF. Targeting patient-specific activation pathways that flowed from the PV antra to the left atrial body using PVI resulted in AF termination during the procedure. These PV activation flow pathways may correspond to the presence of drivers in the PV regions.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Child, Nicholas $u School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom
- 700 1_
- $a Porter, Bradley $u School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom
- 700 1_
- $a Sim, Iain $u School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom
- 700 1_
- $a Whitaker, John $u School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom
- 700 1_
- $a Clayton, Richard H $u INSIGNEO Institute for In Silico Medicine and Department of Computer Science, University of Sheffield, Sheffield, United Kingdom
- 700 1_
- $a Laughner, Jacob I $u Boston Scientific Corp, St. Paul, MN, United States
- 700 1_
- $a Shuros, Allan $u Boston Scientific Corp, St. Paul, MN, United States
- 700 1_
- $a Neuzil, Petr $u Department of Cardiology, Na Holmolce Hospital, Prague, Czechia
- 700 1_
- $a Williams, Steven E $u School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom
- 700 1_
- $a Razavi, Reza S $u School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom
- 700 1_
- $a O'Neill, Mark $u School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom
- 700 1_
- $a Rinaldi, Christopher A $u Department of Cardiology, Guy's and St Thomas' Hospital, London, United Kingdom
- 700 1_
- $a Taggart, Peter $u Institute of Cardiovascular Science, University College London, London, United Kingdom
- 700 1_
- $a Wright, Matt $u Department of Cardiology, Guy's and St Thomas' Hospital, London, United Kingdom
- 700 1_
- $a Gill, Jaswinder S $u Department of Cardiology, Guy's and St Thomas' Hospital, London, United Kingdom
- 700 1_
- $a Niederer, Steven A $u School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom
- 773 0_
- $w MED00174601 $t Frontiers in physiology $x 1664-042X $g Roč. 12, č. - (2021), s. 707189
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34646149 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220107 $b ABA008
- 991 __
- $a 20220112153653 $b ABA008
- 999 __
- $a ind $b bmc $g 1745571 $s 1152828
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 12 $c - $d 707189 $e 20210927 $i 1664-042X $m Frontiers in physiology $n Front. physiol. $x MED00174601
- LZP __
- $a Pubmed-20220107